{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:26:06Z","timestamp":1773062766182,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"DOI":"10.7759\/cureus.104895","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:57:11Z","timestamp":1773050231000},"source":"Crossref","is-referenced-by-count":0,"title":["Human Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) and p16 Expression in Squamous Cell Carcinoma of the Head and Neck"],"prefix":"10.7759","author":[{"given":"Umasankary","family":"Calaisselvane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Moses","family":"Ambroise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sithananda Kumar","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans CR","year":"2018","unstructured":"Leemans CR, Snijders PJ, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018, 18:269-82. 10.1038\/nrc.2018.11","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel RL","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022, 72:7-33. 10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya S","year":"2009","unstructured":"Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009, 45:309-16. 10.1016\/j.oraloncology.2008.06.002","journal-title":"Oral Oncol"},{"key":"ref4","article-title":"Smoking and drinking in relation to oral and pharyngeal cancer","volume":"48","author":"Blot WJ","year":"1988","unstructured":"Blot WJ, McLaughlin JK, Winn DM, et al.. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988, 48:3282-7.","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium","volume":"18","author":"Hashibe M","year":"2009","unstructured":"Hashibe M, Brennan P, Chuang SC, et al.. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009, 18:541-50. 10.1158\/1055-9965.EPI-08-0347","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","unstructured":"Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015, 517.576-82. 10.1038\/nature14129","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.12.017","article-title":"Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment","volume":"91","author":"Marur S","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016, 91:386-96. 10.1016\/j.mayocp.2015.12.017","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coms.2014.01.001","article-title":"Epidemiologic trends in head and neck cancer and aids in diagnosis","volume":"26","author":"Vigneswaran N","year":"2014","unstructured":"Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014, 26:123-41. 10.1016\/j.coms.2014.01.001","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell JL","year":"2013","unstructured":"Bell JL, W\u00e4chter K, M\u00fchleck B, Pazaitis N, K\u00f6hn M, Lederer M, H\u00fcttelmaier S. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?. Cell Mol Life Sci. 2013, 70:2657-75. 10.1007\/s00018-012-1186-z","journal-title":"Cell Mol Life Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.206","article-title":"IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype","volume":"22","author":"K\u00f6bel M","year":"2009","unstructured":"K\u00f6bel M, Xu H, Bourne PA, et al.. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol. 2009, 22:469-75. 10.1038\/modpathol.2008.206","journal-title":"Mod Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang KK","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, et al.. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010, 363:24-35. 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin D","year":"2010","unstructured":"Rischin D, Young RJ, Fisher R, et al.. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010, 28:4142-8. 10.1200\/JCO.2010.29.2904","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-009-0100-y","article-title":"The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer","volume":"3","author":"Westra WH","year":"2009","unstructured":"Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009, 3:78-81. 10.1007\/s12105-009-0100-y","journal-title":"Head Neck Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison ML","year":"2015","unstructured":"Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015, 33:3235-42. 10.1200\/JCO.2015.61.6995","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_252_20","article-title":"Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters","volume":"25","author":"Pandey P","year":"2021","unstructured":"Pandey P, Ralli M, Dixit A, Agarwal S, Chaturvedi V, Sawhney A, Agarwal R. Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters. J Oral Maxillofac Pathol. 2021, 25:74-81. 10.4103\/jomfp.JOMFP_252_20","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740601","article-title":"A study of head and neck cancer patients with reference to tobacco use, gender, and subsite distribution","volume":"11","author":"Chauhan R","year":"2022","unstructured":"Chauhan R, Trivedi V, Rani R, Singh U. A study of head and neck cancer patients with reference to tobacco use, gender, and subsite distribution. South Asian J Cancer. 2022, 11:46-51. 10.1055\/s-0041-1740601","journal-title":"South Asian J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30712","article-title":"Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India","volume":"141","author":"Gheit T","year":"2017","unstructured":"Gheit T, Anantharaman D, Holzinger D, et al.. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer. 2017, 141:143-51. 10.1002\/ijc.30712","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.2.529","article-title":"Demographic profile of p16 immunopositive and HPV DNA PCR positive oral squamous cell carcinoma in a large cohort of Indian patients","volume":"23","author":"Naz F","year":"2022","unstructured":"Naz F, Verma H, Tanveer N, Sudheer AK, Kakkar A, Tanwar P. Demographic profile of p16 immunopositive and HPV DNA PCR positive oral squamous cell carcinoma in a large cohort of Indian patients. Asian Pac J Cancer Prev. 2022, 23:529-36. 10.31557\/APJCP.2022.23.2.529","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.151447","article-title":"Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma","volume":"12","author":"Ralli M","year":"2016","unstructured":"Ralli M, Singh S, Yadav SP, Sharma N, Verma R, Sen R. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther. 2016, 12:232-7. 10.4103\/0973-1482.151447","journal-title":"J Cancer Res Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26195","article-title":"Human papillomavirus status in young patients with head and neck squamous cell carcinoma","volume":"130","author":"van Monsjou HS","year":"2012","unstructured":"van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer. 2012, 130:1806-12. 10.1002\/ijc.26195","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2531-2","article-title":"Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16","volume":"144","author":"Biesaga B","year":"2018","unstructured":"Biesaga B, Mucha-Ma\u0142ecka A, Janecka-Wid\u0142a A, et al.. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16. J Cancer Res Clin Oncol. 2018, 144:63-73. 10.1007\/s00432-017-2531-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08213-9","article-title":"Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes","volume":"21","author":"Arsa L","year":"2021","unstructured":"Arsa L, Siripoon T, Trachu N, et al.. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes. BMC Cancer. 2021, 21:504. 10.1186\/s12885-021-08213-9","journal-title":"BMC Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-020-00391-1","article-title":"The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-\u03baB expression in head and neck squamous cell carcinomas in Southwestern Iran","volume":"52","author":"Pakdel F","year":"2021","unstructured":"Pakdel F, Farhadi A, Pakdel T, Andishe-Tadbir A, Alavi P, Behzad-Behbahani A, Ashraf MJ. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-\u03baB expression in head and neck squamous cell carcinomas in Southwestern Iran. Braz J Microbiol. 2021, 52:195-206. 10.1007\/s42770-020-00391-1","journal-title":"Braz J Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6352","article-title":"IMP3 and p16 expression in squamous cell carcinoma of the head and neck: a comparative immunohistochemical analysis","volume":"14","author":"Riener MO","year":"2017","unstructured":"Riener MO, Hoegel J, Iro H, Hartmann A, Agaimy A. IMP3 and p16 expression in squamous cell carcinoma of the head and neck: a comparative immunohistochemical analysis. Oncol Lett. 2017, 14:1665-70. 10.3892\/ol.2017.6352","journal-title":"Oncol Lett"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34124","article-title":"Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time","volume":"128","author":"Scott-Wittenborn N","year":"2022","unstructured":"Scott-Wittenborn N, D'Souza G, Tewari S, et al.. Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time. Cancer. 2022, 128:1767-74. 10.1002\/cncr.34124","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv403","article-title":"HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients","volume":"108","author":"Castellsagu\u00e9 X","year":"2016","unstructured":"Castellsagu\u00e9 X, Alemany L, Quer M, et al.. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016, 108:djv403. 10.1093\/jnci\/djv403","journal-title":"J Natl Cancer Inst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200201000-00003","article-title":"American adolescents: sexual mixing patterns, bridge partners, and concurrency","volume":"29","author":"Ford K","year":"2002","unstructured":"Ford K, Sohn W, Lepkowski J. American adolescents: sexual mixing patterns, bridge partners, and concurrency. Sex Transm Dis. 2002, 29:13-9. 10.1097\/00007435-200201000-00003","journal-title":"Sex Transm Dis"},{"key":"ref28","article-title":"Determinants of youth sexual behaviour: program implications for India","volume":"16","author":"Joshi B","year":"2011","unstructured":"Joshi B, Chauhan S. Determinants of youth sexual behaviour: program implications for India. East J Med. 2011, 16:113-21.","journal-title":"East J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S128810","article-title":"Prognostic value of high IMP3 expression in solid tumors: a meta-analysis","volume":"10","author":"Chen L","year":"2017","unstructured":"Chen L, Xie Y, Li X, et al.. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. Onco Targets Ther. 2017, 10:2849-63. 10.2147\/OTT.S128810","journal-title":"Onco Targets Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174306","article-title":"IMP3 protein overexpression is linked to unfavorable outcome in laryngeal squamous cell carcinoma","volume":"13","author":"Mar\u017ei\u0107 D","year":"2021","unstructured":"Mar\u017ei\u0107 D, Mariji\u0107 B, Braut T, et al.. IMP3 protein overexpression is linked to unfavorable outcome in laryngeal squamous cell carcinoma. Cancers (Basel). 2021, 13:4306. 10.3390\/cancers13174306","journal-title":"Cancers (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2011.01019.x","article-title":"Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma","volume":"40","author":"Lin CY","year":"2011","unstructured":"Lin CY, Chen ST, Jeng YM, et al.. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med. 2011, 40:699-705. 10.1111\/j.1600-0714.2011.01019.x","journal-title":"J Oral Pathol Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.04.002","article-title":"Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma","volume":"44","author":"Chen K","year":"2013","unstructured":"Chen K, Cornejo KM, Ye W, Wu Q, Liang J, Jiang Z. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma. Hum Pathol. 2013, 44:2126-31. 10.1016\/j.humpath.2013.04.002","journal-title":"Hum Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.12.020","article-title":"Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm","volume":"44","author":"Morimatsu K","year":"2013","unstructured":"Morimatsu K, Aishima S, Yamamoto H, et al.. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm. Hum Pathol. 2013, 44:1714-21. 10.1016\/j.humpath.2012.12.020","journal-title":"Hum Pathol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00684","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the College of American Pathologists Guideline","volume":"36","author":"Fakhry C","year":"2018","unstructured":"Fakhry C, Lacchetti C, Rooper LM, et al.. Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018, 36:3152-61. 10.1200\/JCO.18.00684","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2016.06.006","article-title":"Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia","volume":"122","author":"Bhosale PG","year":"2016","unstructured":"Bhosale PG, Pandey M, Desai RS, Patil A, Kane S, Prabhash K, Mahimkar MB. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016, 122:609-618.e7. 10.1016\/j.oooo.2016.06.006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20215046","article-title":"p16 expression and clinicopathological features of oral and oropharyngeal squamous cell carcinoma","volume":"10","author":"Raphael R","year":"2021","unstructured":"Raphael R, Priya PV, Anju CK, Sankar S. p16 expression and clinicopathological features of oral and oropharyngeal squamous cell carcinoma. Int J Res Med Sci. 2021, 10:147-53. 10.18203\/2320-6012.ijrms20215046","journal-title":"Int J Res Med Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-020-01145-z","article-title":"Clinical and histopathological correlation of p16 and p53 expression in oral cancer","volume":"12","author":"Agarwal VK","year":"2021","unstructured":"Agarwal VK, Sharma R, Gahlot G, Arnav A. Clinical and histopathological correlation of p16 and p53 expression in oral cancer. Indian J Surg Oncol. 2021, 12:164-8. 10.1007\/s13193-020-01145-z","journal-title":"Indian J Surg Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.19.8351","article-title":"Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression","volume":"15","author":"Ramshankar V","year":"2014","unstructured":"Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev. 2014, 15:8351-9. 10.7314\/apjcp.2014.15.19.8351","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.524928","article-title":"Feasibility of immunohistochemical p16 staining in the diagnosis of human papillomavirus infection in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis","volume":"10","author":"Wang H","year":"2020","unstructured":"Wang H, Zhang Y, Bai W, et al.. Feasibility of immunohistochemical p16 staining in the diagnosis of human papillomavirus infection in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Front Oncol. 2020, 10:524928. 10.3389\/fonc.2020.524928","journal-title":"Front Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82999-3","article-title":"Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma","volume":"11","author":"Trinh JM","year":"2021","unstructured":"Trinh JM, Thomas J, Salleron J, Henrot P. Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma. Sci Rep. 2021, 11:3314. 10.1038\/s41598-021-82999-3","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12382","article-title":"Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients","volume":"22","author":"Sannigrahi MK","year":"2016","unstructured":"Sannigrahi MK, Singh V, Sharma R, Panda NK, Radotra BD, Khullar M. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients. Oral Dis. 2016, 22:62-8. 10.1111\/odi.12382","journal-title":"Oral Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470972-human-insulin-like-growth-factor-ii-mrna-binding-protein-3-imp3-and-p16-expression-in-squamous-cell-carcinoma-of-the-head-and-neck","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:57:13Z","timestamp":1773050233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470972-human-insulin-like-growth-factor-ii-mrna-binding-protein-3-imp3-and-p16-expression-in-squamous-cell-carcinoma-of-the-head-and-neck"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.104895","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}